David A. Stein
24Patents
16h-index
15Co-inventors
74Inventor score
Filing activity: Oct 16, 2002 → Apr 9, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7468418B2 | Compositions for enhancing transport of molecules into cells | Chemistry; Metallurgy | 113 | Expired |
| US6828105B2 | Antisense antiviral agent and method for treating ssRNA viral infection | Emerging Cross-Sectional Technologies | 73 | Expired |
| US7507196B2 | Antisense antiviral compounds and methods for treating a filovirus infection | Chemistry; Metallurgy | 47 | Expired |
| US7524829B2 | Antisense antiviral compounds and methods for treating a filovirus infection | Chemistry; Metallurgy | 46 | Expired |
| US7582615B2 | Antisense antiviral compound and method for treating arenavirus infection | Chemistry; Metallurgy | 41 | Active |
| US8524676B2 | Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds | Emerging Cross-Sectional Technologies | 38 | Active |
| US8785407B2 | Antisense antiviral agent and method for treating ssRNA viral infection | Human Necessities | 38 | Active |
| US8906872B2 | Antisense antiviral compound and method for treating ssRNA viral infection | Emerging Cross-Sectional Technologies | 36 | Active |
| US8618270B2 | Oligonucleotide analog and method for treating flavivirus infections | Emerging Cross-Sectional Technologies | 35 | Active |
| US8759307B2 | Oligonucleotide compound and method for treating nidovirus infections | Chemistry; Metallurgy | 35 | Active |
| US8129352B2 | Antisense antiviral compound and method for treating ssRNA viral infection | Emerging Cross-Sectional Technologies | 32 | Expired |
| US8084433B2 | Antisense antiviral compound and method for treating ssRNA viral infection | Emerging Cross-Sectional Technologies | 32 | Expired |
| US8030292B2 | Antisense antiviral compounds and methods for treating a filovirus infection | Chemistry; Metallurgy | 31 | Active |
| US8030291B2 | Antisense antiviral compounds and methods for treating a filovirus infection | Chemistry; Metallurgy | 31 | Active |
| US8168604B2 | Antisense antiviral compounds and methods for treating a filovirus infection | Chemistry; Metallurgy | 29 | Active |
| US7807801B2 | Oligonucleotide analog and method for treating flavivirus infections | Emerging Cross-Sectional Technologies | 28 | Active |
| US8329668B2 | Antisense antiviral compound and method for treating picornavirus infection | Chemistry; Metallurgy | 16 | Active |
| US8357664B2 | Antisense antiviral compound and method for treating influenza viral infection | Chemistry; Metallurgy | 3 | Active |
| US10479996B2 | Antisense antiviral compound and method for treating ss/RNA viral infection | Emerging Cross-Sectional Technologies | 3 | Active |
| US9572899B2 | Compositions for enhancing transport of molecules into cells | Chemistry; Metallurgy | 2 | Active |
| US9328347B2 | siRNA useful in the treatment of flavivirus infection | Chemistry; Metallurgy | 2 | Active |
| US10300149B2 | Compositions for enhancing transport of molecules into cells | Chemistry; Metallurgy | 1 | Active |
| US9347063B2 | Oligonucleotide analog and method for treating flavivirus infections | Emerging Cross-Sectional Technologies | 0 | Active |
| US10905782B2 | Compositions for enhancing transport of molecules into cells | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.